In vitro susceptibility of Mycobacterium tuberculosis clinical isolates to garenoxacin and DA-7867 (Q34076988)

30 July 2017

In vitro susceptibility of Mycobacterium tuberculosis clinical isolates to garenoxacin and DA-7867 (English)

1 reference

Mycobacterium tuberculosis

30 July 2017

0 references

author

Carmen A Molina-Torres

object named as

Carmen Molina-Torres

8

0 references

Jorge Castro-Garza

object named as

Jorge Castro-Garza

2

0 references

Lucio Vera-Cabrera

1

object named as

Lucio Vera-Cabrera

1 reference

30 July 2017

Adrian Rendon

3

1 reference

30 July 2017

Jorge Ocampo-Candiani

4

1 reference

30 July 2017

Oliverio Welsh

5

1 reference

30 July 2017

Sung Hak Choi

6

1 reference

30 July 2017

Kym Blackwood

7

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 October 2005

1 reference

Antimicrobial Agents and Chemotherapy

30 July 2017

1 reference

30 July 2017

49

1 reference

30 July 2017

10

1 reference

30 July 2017

4351-4353

1 reference

A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis

30 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1251498

Mycobacterium tuberculosis DNA gyrase: interaction with quinolones and correlation with antimycobacterial drug activity

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1251498

In vitro activities of new antimicrobials against Nocardia brasiliensis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1251498

In vitro activities of DA-7867, a novel oxazolidinone, against recent clinical isolates of aerobic and anaerobic bacteria

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1251498

The global situation of MDR-TB.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1251498

The TB epidemic from 1992 to 2002.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1251498

In vitro activities of linezolid against clinical isolates of Mycobacterium tuberculosis that are susceptible or resistant to first-line antituberculous drugs

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1251498

Activities of several novel oxazolidinones against Mycobacterium tuberculosis in a murine model

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1251498

Rapid, low-technology MIC determination with clinical Mycobacterium tuberculosis isolates by using the microplate Alamar Blue assay

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1251498

In vitro activity of moxifloxacin, levofloxacin, gatifloxacin and linezolid against Mycobacterium tuberculosis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1251498

10.1128/AAC.49.10.4351-4353.2005

28 October 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference

30 July 2017

1 reference